The stability of theophylline cocrystals composed of acidic (glutaric acid), basic (isonicotinamide), or neutral (benzamide) coformers was evaluated in the presence of several excipients. Tablets of theophylline-glutaric acid (TG) and theophylline-isonicotinamide (TINT) cocrystals were stable “as is” (no excipient) after storage at 40 °C/75% RH for 1 week. However, TG and TINT cocrystals dissociated rapidly in the presence of basic and acidic excipients, respectively. The dissociation reaction was water-mediated, and theophylline, the reaction product, was identified by powder X-ray diffractometry. In the case of theophylline-benzamide cocrystal, storage of tablets with and without excipients at 40 °C/75% RH for 1 week resulted in a cocryst...
Pharmaceutical cocrystals, which contain at least one active pharmaceutical ingredient (API), are st...
The selection of the crystalline phases in a form of molecular cocrystals has become scientific chal...
The charge density distribution in a novel cocrystal (1) complex of 1,3-dimethylxanthine (theophylli...
Tablets containing a theophylline–glutaric acid (TG) cocrystal dissociated rapidly forming crystalli...
Cocrystal formation is widely used to modify and optimize the physicochemical properties of an activ...
Caffeine–oxalic acid cocrystal, widely reported to be stable under high humidity, dissociated in the...
The primary aim of pharmaceutical materials engineering is the successful formulation and process de...
peer-reviewedDiscovery of novel cocrystal systems and improvement of their physicochemical propertie...
During drug research and development, improving the solubility of poorly water soluble drugs without...
Solubility enhancement of poorly-soluble active pharmaceutical ingredients (APIs) remains a scientif...
Pharmaceutical cocrystals comprise one active pharmaceutical ingredient (API) and at least one small...
In recent years, there has been an increasing interest in cocrystallization of active pharmaceutical...
Cocrystals have recently gained attention as attractive alternate solid forms for drug development. ...
Pharmaceutical co-crystallization has been a recent focus because of its potential to improve the ef...
The stability of different theophylline cocrystals under milling conditions was investigated by comp...
Pharmaceutical cocrystals, which contain at least one active pharmaceutical ingredient (API), are st...
The selection of the crystalline phases in a form of molecular cocrystals has become scientific chal...
The charge density distribution in a novel cocrystal (1) complex of 1,3-dimethylxanthine (theophylli...
Tablets containing a theophylline–glutaric acid (TG) cocrystal dissociated rapidly forming crystalli...
Cocrystal formation is widely used to modify and optimize the physicochemical properties of an activ...
Caffeine–oxalic acid cocrystal, widely reported to be stable under high humidity, dissociated in the...
The primary aim of pharmaceutical materials engineering is the successful formulation and process de...
peer-reviewedDiscovery of novel cocrystal systems and improvement of their physicochemical propertie...
During drug research and development, improving the solubility of poorly water soluble drugs without...
Solubility enhancement of poorly-soluble active pharmaceutical ingredients (APIs) remains a scientif...
Pharmaceutical cocrystals comprise one active pharmaceutical ingredient (API) and at least one small...
In recent years, there has been an increasing interest in cocrystallization of active pharmaceutical...
Cocrystals have recently gained attention as attractive alternate solid forms for drug development. ...
Pharmaceutical co-crystallization has been a recent focus because of its potential to improve the ef...
The stability of different theophylline cocrystals under milling conditions was investigated by comp...
Pharmaceutical cocrystals, which contain at least one active pharmaceutical ingredient (API), are st...
The selection of the crystalline phases in a form of molecular cocrystals has become scientific chal...
The charge density distribution in a novel cocrystal (1) complex of 1,3-dimethylxanthine (theophylli...